RBC Capital Maintains Outperform on Ardent Health, Lowers Price Target to $13

Ardent Health, Inc.

Ardent Health, Inc.

ARDT

0.00

RBC Capital analyst Ben Hendrix maintains Ardent Health (NYSE: ARDT) with a Outperform and lowers the price target from $14 to $13.